4-(Bromomethyl)pyridine hydrobromide

Marketed by Shanghai Rlavie Technology Co.,ltd, 4-(Bromomethyl)pyridine hydrobromide (CAS 73870-24-3) is a pharmaceutical-grade specialty intermediate, produced to Chinese Pharmacopoeia (ChP), US Pharmacopoeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP), International Pharmacopoeia, and Indian Pharmacopoeia (IP) standards. The company is the direct manufacturer of the product, with distribution reaching North and South America, Europe, Asia, Australasia, the Middle East, and Africa.